HHS to cut 10,000 staff in major restructuring under RFK Jr.
Bio Pharma Dive
MARCH 27, 2025
The FDA will lose about 3,500 employees under the plans, although HHS said drug, medical device and food reviewers will not be affected.
Thu.Mar 27, 2025
319 
Blockbuster potential drugs ruled the 2024 pipeline with 53% rise over 2023
Pharmaceutical Technology
MARCH 27, 2025
GLP-1RAs were the big game changer, boosting average forecast sales and return on investment rates.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy
Bio Pharma Dive
MARCH 27, 2025
The biotech is slashing a third of its workforce and more than half of its executive team in moves it called “necessary in today’s challenging financial and competitive environment.
HHS announces major workforce cuts and reorganisation
Pharmaceutical Technology
MARCH 27, 2025
The US Food and Drug Administration (FDA) will see the biggest cuts, with 19% of jobs in the agency being eliminated.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Alcon buys majority stake in IPO-seeking cell therapy startup Aurion
Bio Pharma Dive
MARCH 27, 2025
The share acquisition is the latest twist in a dispute between Alcon and fellow Aurion shareholder Deerfield Management over the direction of the company, which filed to go public in January.
Soleno wins FDA approval for Prader-Willi hyperphagia treatment
Pharmaceutical Technology
MARCH 27, 2025
The drug, named Vykat XR, will be available to patients in the US with Prader-Willi syndrome from April 2025.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
How bioconjugation is unlocking the next generation of drug development
Pharmaceutical Technology
MARCH 27, 2025
Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across modalities.
FDA fast-tracks Sanofi's experimental chlamydia vaccine
pharmaphorum
MARCH 27, 2025
Sanofi is preparing to start human testing of its chlamydia vaccine, now fast-tracked by the FDA, that it hopes will be the first to reach the market.
Ionis and Sobi agree on olezarsen commercialisation
Pharmaceutical Technology
MARCH 27, 2025
Ionis has entered a licence agreement with Sobi in which the latter obtains exclusive rights to commercialise olezarsen.
Veterans Affairs Research Under Threat
JAMA Internal Medicine
MARCH 27, 2025
This Viewpoint discusses the critical importance of continued funding for the intramural research program in the Department of Veterans Affairs.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Tribune gains funds to advance scar tissue therapies
Pharmaceutical Technology
MARCH 27, 2025
Tribune has secured $39.9m in seed and Series A funding for its therapy portfolio aimed at the central drivers of scar tissue formation.
Amivantamab plus lazertinib shows survival benefit in lung cancer
Pharma Times
MARCH 27, 2025
Janssen drug combination extends life expectancy during trial
AGA overhauls UC treatment pathway: early, high-efficacy therapies now preferred
Pharmaceutical Technology
MARCH 27, 2025
In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the pharmacological management of moderate-to-severe ulcerative colitis (UC) in gastroenterology.
J&J throws the gauntlet down to AZ with new survival data
pharmaphorum
MARCH 27, 2025
New survival data from MARIPOSA for Johnson & Johnson's Rybrevant/Lazcluze combination in lung cancer could spell trouble for AstraZeneca
EC approves MSD’s pneumococcal 21-valent conjugate Capvaxive
Pharmaceutical Technology
MARCH 27, 2025
MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease and pneumonia.
Alcon claims control of cell therapy firm Aurion
pharmaphorum
MARCH 27, 2025
Eyecare giant Alcon has bought a majority stake in cell therapy startup Aurion Biotech, replacing the company's chief executive
Hubs East 2025: The Role of Emotional Support in Improving Patient Adherence
Pharmaceutical Commerce
MARCH 27, 2025
Jen Butler, chief commercial officer, Pleio, discusses the effectiveness of peer-to-patient outreach when starting specialty medications.
First gene-edited pig liver transplant 'worked for 10 days'
pharmaphorum
MARCH 27, 2025
In a xenotransplant milestone, scientists have carried out the first transplant of a genetically modified pig liver into a brain-dead human patient
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
LillyDirect Platform to Help Provide Alzeheimer’s Support
Pharmaceutical Commerce
MARCH 27, 2025
The tool will focus on educational resources by offering both in-person and telehealth support for individuals living in the United States.
HHS plans 10,000 more job cuts, taking target to 20,000
pharmaphorum
MARCH 27, 2025
HHS Secretary Kennedy has said he intends to save $1.
Pharma’s Response to the Biosecure Act
Pharmaceutical Commerce
MARCH 27, 2025
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDOs national life sciences co-leader, details the Biosecure Act, including the ways pharma companies are preparing for it, especially from a compliance standpoint.
Crucial Data Solutions Launches Industry-First Subscription Model to Modernize Clinical Trial Contracting and Pricing
Crucial Data Soutions
MARCH 27, 2025
New model empowers CROs to grow revenue, reduces costs for sponsors, and accelerates time to market RENO, NV, UNITED STATES, The post Crucial Data Solutions Launches Industry-First Subscription Model to Modernize Clinical Trial Contracting and Pricing appeared first on Crucial Data Solutions.
Pharma Pulse 3/27/25: Ethical Considerations for AI Use in Medication Access, The Future of PBMs in 2025 & more
Pharmaceutical Commerce
MARCH 27, 2025
The latest news for pharma industry insiders.
How to Use Data & Analytics to Improve Patient Recruitment Outcomes
Antidote
MARCH 27, 2025
Recruiting the right patients for clinical trials remains a major hurdle, with nearly 80% of trials missing enrollment deadlinesdriving up costs and risking study failure.
Grand Rounds March 21, 2025: Generative Artificial Intelligence in Clinical Trials: A Driver of Efficiency and Democratization of Care (Alexander J. “AJ” Blood, MD, MSc)
Rethinking Clinical Trials
MARCH 27, 2025
Speaker Alexander J. AJ Blood, MD, MSc Associate Director, Accelerator for Clinical Transformation Research Group Instructor of Medicine at Harvard Medical School Cardiologist and Intensivist Brigham and Womens Hospital Slides Keywords Artificial Intelligence; Cost; Large Language Models; Enrollment; Eligibility; Recruitment Key Points The Accelerator for Clinical Transformation (ACT) is a research group that seeks to use emerging technology to try and expand access to
Parliamentary Panel asks govt to expand scope of NLEM to include more life-saving medicines
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 27, 2025
The Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceuticals (DoP) to expand the scope of the National List of Essential Medicines (NLEM) to include more essential and widely used medicines.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Genome editing offers hope for genetic hearing loss
Pharma Times
MARCH 27, 2025
New therapy developed to repair GJB2 R75W mutation
How Often You Should Wash Your Exercise Clothes, According to Science
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 27, 2025
(Olga Ihnatsyeva/iStock/Getty Images Plus) When you come home from a run or a sweaty gym session, do you immediately fling your clothes into the washing machine for a hot cycle? Or do you leave them on a chair (or the floordrobe) so you can wear them again tomorrow?
Cassava Sciences Ends Simufilam Alzheimer’s Program After Another Phase III Failure
XTalks
MARCH 27, 2025
Cassava Sciences has officially ended its Alzheimers drug development program for simufilam. The termination came after the drug failed to meet its co-primary, secondary and exploratory biomarker endpoints in the Phase III REFOCUS-ALZ clinical trial. Cassava discontinued the trial on November 25, 2024, after a previous study, the Phase III RETHINK-ALZ trial, did not meet its co-primary endpoints.
The Healthcare Businesswomen’s Association (HBA) Announces its 2025 Rising Star and Luminary Honorees
Pharma Marketing Network
MARCH 27, 2025
The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Nominated by the HBAs Corporate Partners, these leaders are not only exceptional contributors within their companies but also powerful advocates for health equity and women’s advancement globally, significantly contributing to the HBAs vision of Creating Women Leaders for Life.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content